Fleischner Criteria: Managing Pulmonary Nodules on CT
The Fleischner Criteria are internationally recognized guidelines for the evaluation and follow-up of incidentally detected pulmonary nodules on CT scans, helping physicians assess cancer risk.
Things worth knowing about "Fleischner Criteria"
The Fleischner Criteria are internationally recognized guidelines for the evaluation and follow-up of incidentally detected pulmonary nodules on CT scans, helping physicians assess cancer risk.
What Are the Fleischner Criteria?
The Fleischner Criteria are evidence-based recommendations issued by the Fleischner Society, an international scientific organization dedicated to thoracic radiology and related disciplines. These guidelines define how pulmonary nodules -- small, rounded lesions in the lung -- that are discovered incidentally on computed tomography (CT) scans should be evaluated and managed. The primary goal is to avoid unnecessary invasive procedures while ensuring that potentially malignant lesions are detected early.
Background and Clinical Importance
With the widespread use of CT imaging, pulmonary nodules are increasingly discovered as incidental findings -- that is, during scans performed for unrelated reasons. The vast majority of these nodules are benign; however, a small proportion may represent early-stage lung cancer. The Fleischner Criteria provide a structured, risk-adapted framework that helps clinicians decide when follow-up imaging is needed and when further investigation such as biopsy is warranted.
Categories and Recommendations
The criteria categorize nodules based on their appearance, size, and the risk profile of the patient, providing tailored management recommendations for each group.
Solid Nodules
Solid nodules appear as uniformly dense lesions on CT. Recommendations are stratified by size and patient risk:
- Less than 6 mm: No routine follow-up is recommended for low-risk patients. An optional CT at 12 months may be considered for high-risk patients.
- 6 to 8 mm: Follow-up CT is recommended at 6 to 12 months, with an additional scan at 18 to 24 months if the nodule remains stable.
- Greater than 8 mm: Follow-up CT at 3 months, with consideration of PET-CT or tissue biopsy for further characterization.
Subsolid Nodules
Subsolid nodules include those with ground-glass opacity components and are divided into two subtypes:
- Pure ground-glass nodules smaller than 6 mm: No follow-up is required.
- Pure ground-glass nodules larger than 6 mm: Follow-up CT at 6 to 12 months, then every 2 years for up to 5 years.
- Part-solid nodules smaller than 6 mm: Follow-up CT at 3 to 6 months is advised.
- Part-solid nodules larger than 6 mm: Follow-up CT at 3 to 6 months; if the solid component persists at 6 mm or more, biopsy or surgical resection should be considered.
Multiple Nodules
When multiple nodules are present, management is guided by the dominant (largest or most suspicious) nodule, while the overall clinical context of the patient must always be taken into account.
Risk Factors
The Fleischner Criteria differentiate between patients at low risk and those at elevated risk for lung malignancy. Key risk factors include:
- Current or prior smoking history
- Occupational exposure to asbestos, radon, or other carcinogens
- Family history of lung cancer
- Known or prior malignancy
Current Version of the Guidelines
The Fleischner Criteria were first published in 2005 and have been updated several times since. The most current version, published in 2017 in the journal Radiology, is widely regarded as the international gold standard for pulmonary nodule management.
Limitations and Applicability
The Fleischner Criteria apply exclusively to incidentally detected nodules in adults aged 35 years or older who do not have a known active malignancy. They are not intended for use in patients enrolled in formal lung cancer screening programs, for whom separate dedicated guidelines exist (e.g., Lung-RADS criteria).
References
- MacMahon H et al. - Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017;284(1):228-243.
- Naidich DP et al. - Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT. Radiology. 2013;266(1):304-317.
- Gould MK et al. - Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer? CHEST. 2013;143(5 Suppl):e93S-e120S.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.